A new clinical trial led by researchers at Queen Mary University of London suggests that a single injection given every six months may significantly lower blood pressure over time. The findings, published in JAMA , point to a long-lasting treatment option that could improve how hypertension is managed.
The global study, called KARDIA-2, included 663 adults with high blood pressure that was not well controlled with their usual medications.
Trial Finds Added Benefit Over Standard Treatment
Participants in the trial received an injection of the experimental drug zilebesiran in addition to their existing blood pressure treatments. Researchers found that patients who received the injection alongside standard therapy experienced greater reductions in blood pressure compared to those who stayed on standard treatment alone.
These results could have wide-reaching implications.…